Europe Positive Airway Pressure (PAP) Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 141 | Report Code: BMIRE00032122 | Category: Life Sciences
No. of Pages: 141 | Report Code: BMIRE00032122 | Category: Life Sciences
The Europe positive airway pressure (PAP) devices market size is expected to reach US$ 2,997.83 million by 2031 from US$ 1,803.88 million in 2023. The market is estimated to record a CAGR of 6.6% from 2023 to 2031.
The Europe PAP devices market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany and Italy are expected to account for a significant market share during the forecast period. Further, the market in France, the UK, and Spain is likely to experience lucrative opportunities in the coming years. The growing geriatric population with a greater risk of sleep apnea; increasing adoption of PAP devices; rising prevalence of chronic obstructive pulmonary disease (COPD), sleep apnea, and others; and growing developments by the players operating in Europe are fueling the regional market.
Key segments that contributed to the derivation of the Europe positive airway pressure (PAP) devices market analysis are product type, application, and end user.
More people are seeking medical attention for sleep problems as awareness grows. As a result, disorders such as OSA are being diagnosed more frequently and treated with machines that provide CPAP or BiPAP. Government and medical institutions frequently conduct public awareness campaigns for the risks of untreated sleep apnea leading to diabetes and cardiovascular problems. The need for PAP devices is rising due to the campaigns promoting early detection and treatment. Patients and healthcare professionals are paying more attention as the value of sleep health becomes more widely recognized. The market for PAP devices is growing as more people are taking initiatives to look for ways to enhance the quality of their sleep. For example, World Sleep Day was established in 2008 by the World Sleep Day Committee of the World Sleep Society. It is observed annually on the Friday before the March Equinox. The event aims to celebrate the benefits of healthy sleep, raise awareness about the challenges associated with sleep-related issues, and promote the prevention and management of sleep disorders. Each year features a specific theme; for instance, in 2025, the theme will be "Make Sleep Health a Priority," which emphasizes the importance of prioritizing sleep for overall well-being. The sales of PAP devices are expected to rise significantly due to increasing awareness of COPD and other respiratory diseases. The Speak Up for COPD campaign is a global initiative focused on raising awareness and understanding of COPD among policymakers and healthcare decision-makers. Launched in 2021, the campaign aims to amplify the voices of patients, caregivers, and the wider COPD community to prioritize COPD as a critical public health issue. For instance, the EU PAL-COPD Project, funded by Horizon Europe, aims to integrate palliative care into the treatment of individuals with advanced COPD across various European healthcare systems. Coordinated by Vrije Universiteit Brussel, this five-year initiative (2024–2028) seeks to improve the quality of life for both COPD patients and their families. Thus, an increase in awareness of respiratory diseases is likely to create lucrative opportunities in the market.
Based on country, the Europe positive airway pressure (PAP) devices market comprises the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany held the largest share in 2023.
Germany is expected to be among the significant contributors to the global PAP devices market growth owing to the growing aging population. As per the World Population Ageing, nearly 28% of the total population of Germany was aged 60 and above in 2017, and the figure is estimated to reach ~37.6% by 2050. Aging is accompanied by changes in both the quantity and quality of sleep; therefore, obstructive sleep apnea is more prevalent in the older population. The risks of being diagnosed with obstructive sleep apnea increase with age, leading to the need for PAP therapy.
Market players are adopting organic growth strategies for the development of the PAP devices market in Germany. For instance, in September 2023, ResMed Germany initiated a partnership with Nyxoah, a company focused on developing solutions for treating obstructive sleep apnea. The collaboration is increasing awareness about obstructive sleep apnea and catalyzing the use of related therapies in the German market. Both companies are involved in providing obstructive sleep apnea helplines and direct-to-consumer initiatives, as well as conducting sales and marketing efforts targeting ENTs and sleep physicians.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 1,803.88 Million |
| Market Size by 2031 | US$ 2,997.83 Million |
| CAGR (2023 - 2031) | 6.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
|
Some of the key players operating in the market ICU Medical Inc; React Health (Formerly 3B Medical, Inc); Fisher & Paykel Healthcare Corp Ltd; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; Dragerwerk AG & Co KGaA; ResMed Inc; Vyaire Medical Inc; Wellell Inc; Armstrong Medical Ltd; Löwenstein Medical UK Ltd.; BMC Medical Co Ltd; and Narang Medical Limited, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The Europe Positive Airway Pressure (PAP) Devices Market is valued at US$ 1,803.88 Million in 2023, it is projected to reach US$ 2,997.83 Million by 2031.
As per our report Europe Positive Airway Pressure (PAP) Devices Market, the market size is valued at US$ 1,803.88 Million in 2023, projecting it to reach US$ 2,997.83 Million by 2031. This translates to a CAGR of approximately 6.6% during the forecast period.
The Europe Positive Airway Pressure (PAP) Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Positive Airway Pressure (PAP) Devices Market report:
The Europe Positive Airway Pressure (PAP) Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Positive Airway Pressure (PAP) Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Positive Airway Pressure (PAP) Devices Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Positive Airway Pressure (PAP) Devices Market
